Modular Medical (NASDAQ:MODD) Announces Quarterly Earnings Results

Modular Medical (NASDAQ:MODD – Get Free Report) posted its earnings results on Monday. The company reported ($0.90) EPS for the quarter, FiscalAI reports.

Modular Medical Trading Up 1.9%

MODD traded up $0.04 on Tuesday, reaching $1.95. The company had a trading volume of 10,676 shares, compared to its average volume of 127,996. The company has a fifty day moving average of $2.10 and a 200-day moving average of $4.67. The company has a market capitalization of $18.49 million, a P/E ratio of -0.22 and a beta of 0.52. Modular Medical has a one year low of $1.20 and a one year high of $16.20.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on MODD shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Modular Medical in a report on Monday, September 21st. Wall Street Zen upgraded Modular Medical from a “strong sell” rating to a “sell” rating in a research report on Sunday, August 23rd. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

View Our Latest Stock Report on Modular Medical

Institutional Trading of Modular Medical

An institutional investor recently raised its stake in Modular Medical stock. AWM Investment Company Inc. increased its stake in Modular Medical, Inc. (NASDAQ:MODD – Free Report) by 20.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 441,095 shares of the company’s stock after acquiring an additional 74,429 shares during the period. AWM Investment Company Inc. owned approximately 7.38% of Modular Medical worth $1,985,000 at the end of the most recent reporting period. 27.47% of the stock is currently owned by hedge funds and other institutional investors.

About Modular Medical

(Get Free Report)

Modular Medical, Inc. is a medical-device company focused on developing insulin-delivery technology for people with diabetes. Its work centers on making pump therapy simpler and more accessible for people who may find traditional insulin pumps difficult to use. The company’s lead product, MODD1, is a wearable insulin-delivery system designed to provide an alternative to multiple daily insulin injections. Modular Medical describes the device as a simplified pump intended to make insulin delivery easier to manage.

Read More

Earnings History for Modular Medical (NASDAQ:MODD)

Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.